News
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a new strategic direction with an increasing focus on low-dose GLP-1 combination therapy, ...
Hims & Hers Health's Q2 revenue miss and decelerating growth triggered a stock drop. Find out why I maintain a 'Buy' rating ...
Lizzo discussed the realities of her weight lost journey, adding: “There were times when I would eat so much that my stomach ...
At the operating level, EBITDA jumped 39% to ₹367.6 crore in the April-June quarter over ₹264.5 crore last year. The EBITDA ...
Choice of therapy to control high blood sugar may affect survival among older adults with cancer and type 2 diabetes, according to study results.Those who used GLP-1 receptor agonists exhibited ...
Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 millionAs of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, ...
From eggs and oats to beans and lentils, here is a list of food items that can help shedding the extra kilos faster.
Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported ...
Clare Reid, 49, was looking forward to a big trip to Dubai with her daughter and wanted to fit into her holiday clothes, so ...
Two dietitians share how Ozempic affects your body and answer the question: is Ozempic really safe for weight loss? Plus, ...
GPs should monitor patients who have taken weight loss medication ‘for a minimum of one year’ after treatment is completed, ...
Explore how GLP-1a drugs transform the food industry from a threat to an opportunity. Our 36-page strategy briefing outlines the potential for growth by meeting the rising demand for protein, fiber, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results